top of page
Search Results

578 items found for "Cyclin D"

  • Disentangling bias between G q, GRK2, and arrestin3 recruitment to the M 3 muscarinic acetylcholine

    Different agonists can promote differential receptor-induced signaling responses - termed bias - potentially by eliciting different levels of recruitment of effector proteins. activation and recruitment of effector proteins might influence each other, thorough analysis of bias is difficult We measured substantial differences in the agonist efficacies to induce M3R-arrestin3 versus M3R-GRK2 M3R requires similar receptor conformations, whereas requirements for arrestin3 binding to M3R are distinct

  • TeachOpenCADD - A teaching platform for computer-aided drug design

    bioinformatics are powerful tools to build modular, reproducible, and reusable pipelines for computer-aided drug design (CADD). While documentation for such tools is available, only few freely accessible examples teach underlying TeachOpenCADD is a teaching platform developed by students for students, which provides teaching material Details

  • Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...

    Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic OR expression outside of the nose has functions distinct from odor perception, and may contribute to the pathogenesis of disorders including brain diseases and cancers. Although most ORs were not ubiquitously expressed in gliomas, a subset of ORs displayed glioma subtype-specific (mouse Olfr15) was identified as a potential biomarker of favorable overall survival in isocitrate dehydrogenase

  • Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...

    November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID -19 and Other Antibody Therapeutics for Difficult to Treat Diseases " Nov 15, 2021 -- Executive Leadership Team Established with Demonstrated Success in Clinical, Regulatory and Commercial Development -- SOUTH NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA and commercialize an antibody, discovered and optimized by Twist Biopharma, a division of Twist Bioscience

  • Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...

    Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in primary Sjögren's syndrome The etiology of primary Sjögren's syndrome (pSS) remains unknown, and there is no ideal drug In addition, β-arrestin2 depletion downregulated GRP78-ATF6-CHOP apoptosis signaling to alleviate cell apoptosis, and the effect depended on the interaction between GRP78 and β-arrestin2. in the treatment of the human autoimmune disorder pSS.

  • 📰 GPCR Weekly News, October 23 to 29, 2023

    Join us for a deep dive into the world of GPCRs. Save the dates: November 17: Join our final Dr. Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100 Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress Parker Moss to Join Exscientia Development at Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences NEW

  • 📰 GPCR Weekly News

    Below is your Classified GPCR News at a glance for December 12 to December 18th, 2022. : The discovery of VU6046980. and Metabolic Diseases Sosei Heptares Enters R&D Agreements with the University of Oxford and KU Leuven to Identify and Validate Key GPCRs Driving Gastrointestinal and Immune Disorders Inversago Pharma Doses and Obesity Special report 2022: Meet 20 women blazing trails in biopharma R&D ERNEST - 2022 Scientific

  • Targeting Intracellular Allosteric Sites in GPCRs

    For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in understanding allosteric modulation have opened up new avenues for drug development. discovery. such as liver disease, obesity and diabetes (Wold and Zhou 2018).

  • Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..

    Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled Receptor D Induces Release of the Inflammatory Cytokine IL-6 and Is Dependent on NF-κB Signaling G protein-coupled However, involvement of the human Mas-related G-protein coupled receptor D (MRGPRD) in the regulation of the inflammatory mediator interleukin 6 (IL-6) has not been demonstrated to date. Consequently, the dynamic range for IL-6 detection as an assay for β-alanine-mediated activation of MRGPRD

  • The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...

    The mouse cytomegalovirus (MCMV) GPCR, M33, facilitates dendritic cell (DC)-dependent viremia, the extravasation M33 engages Gq/11 to constitutively activate phospholipase C β (PLCβ) and downstream cyclic AMP response-element correlated with reduced mobilisation of lytically-infected DC to draining lymph node high endothelial Taken together, these data demonstrate that key features of the MCMV lifecycle are coordinated in diverse tissues by distinct pathways of the M33 signalling repertoire.

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    For Dr. GPCR News, please subscribe to our monthly newsletter. The first Dr. Allosteric Modulator. α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors GPCR Binders, Drugs, and more Design of Drug Efficacy Guided by Free Energy Simulations of the β2-Adrenoceptor Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide discovery - Design Pharmaceuticals Call for GPCR Papers GPCRs: Signal Transduction.

  • TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi

    What is the molecular basis that determines that GPCRs bind selectively or promiscuously to different Prior to this report we did not know how different serotonin receptor subtypes which share high sequence the development of alternatives to improve drug design to optimize receptor selectivity. These differences are mainly attributed to the characteristic Ras domain distance between Gs and Gi. #GPCR #DrGPCR

  • Location bias contributes to functionally selective responses of biased CXCR3 agonists

    Here, we determine that differential subcellular signaling contributes to the biased signaling generated In a mouse model of contact hypersensitivity, β-arrestin-biased CXCR3-mediated inflammation is dependent Our work demonstrates that differential subcellular signaling is critical to the overall biased response observed at CXCR3, which has important implications for drugs targeting chemokine receptors and other Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

  • Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal

    Though most of these variants exhibit a loss of function, the molecular defects caused by these underlying In this work, we utilize deep mutational scanning to quantitatively compare the plasma membrane expression We identify 69 retinopathy variants, including 20 previously uncharacterized variants, that exhibit diminished relative to thermodynamic estimates for the coupling between binding and folding suggests underlying differences Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE

  • The Gluopsins: Opsins without the Retinal Binding Lysine

    reconstructions discard any sequence without it. Therefore, we wondered: Do opsins exists that have lost this lysine during evolution? Our final opsin phylogeny is the largest to date with 4956 opsins. Like those, they have a derived NPxxY motif. Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE

  • Advancements in G protein-coupled receptor biosensors to study GPCR-G protein coupling

    October 2022 "Enzymatic and cellular signalling biosensors are used to decipher the activities of complex Biosensors for monitoring G protein-coupled receptors (GPCRs), the most drugged class of proteins in Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE

  • Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated

    Deletion of phospholipase Cβ3 (PLCβ3), or selective inhibition of Gβγ regulation of PLCβ3, enhances the Here we investigated a potential mechanism for regulation of PLC signaling downstream of MOR in HEK293 Gq, ex vivo in periaqueductal gray (PAG) slices increased the potency of the selective MOR agonist DAMGO These data support a model where Gq and Gβγ-dependent signaling cooperatively regulate PLC activation to decrease MOR-dependent antinociceptive potency.

  • Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

    November 2022 "Adhesion G-protein-coupled receptors (aGPCRs) play key roles in a diversity of physiologies A hallmark of aGPCR activation is the removal of the inhibitory GAIN domain and the dipping of the cleaved stalk peptide into the ligand-binding pocket of receptors; however, the detailed mechanism remains obscure A detailed analysis of the engagements allows us to design mutations that specifically enhance one pathway Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

  • Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors

    November 2022 "Despite the growing number of G protein-coupled receptor (GPCR) structures, only 39 structures of small organic probe molecules distributed on the protein surface. The method has found druggable sites overlapping with the cocrystallized allosteric ligands in 21 GPCR These sites cluster at nine distinct locations, and each can be found in many different proteins. Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

  • Hear the sounds: the role of G protein-coupled receptors in the cochlea

    The research of GPCRs in the cochlea is essential for the understanding of the cochlea development, hearing disorders, and the treatment for hearing loss. Frizzleds and Lgrs are dominant GPCRs that regulate stem cell self-renew abilities. Moreover, Frizzleds and Celsrs have been demonstrated to play core roles in the modulation of cochlear Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter

  • GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin...

    receptors "Serotonin (or 5-hydroxytryptamine, 5-HT) is an important neurotransmitter that activates 12 different The structures reveal that transmembrane helices TM5 and TM6 alternate lengths as a macro-switch to determine Furthermore, we discover specific residues within TM5 and TM6 that function as micro-switches to form Read more at the source #DrGPCR #GPCR #IndustryNews

  • Activation of the human chemokine receptor CX3CR1 regulated by cholesterol

    However, the drug development of CX3CR1 is hampered partially by the lack of structural information. Together with functional data, the structures reveal the key factors that govern the recognition of CX3CL1 Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein-coupled receptor ) signaling and provide insights into the diversity of G protein coupling." Read more at the source #DrGPCR #GPCR #IndustryNews

  • G protein-coupled receptor signaling: transducers and effectors

    October 2022 "G protein-coupled receptors (GPCRs) are of considerable interest due to their importance in a wide range of physiological functions and in a large number of Food and Drug Administration (FDA )-approved drugs as therapeutic entities. As new technologies are developed and applied to studying GPCR structure and their downstream effectors Read more at the source #DrGPCR #GPCR #IndustryNews

  • The regulation of PKA signaling in obesity and in the maintenance of metabolic health

    October 2022 "The cAMP-dependent protein kinase (PKA) system represents a primary cell-signaling pathway regulates cellular metabolism and emotional and stress responses making it integral in the maintenance and dysregulation While limited, human studies infer differential regulation of the PKA system in obese compared to lean Variants identified in PKA subunit genes cause Cushing syndrome that is characterized by metabolic dysregulation Read more at the source #DrGPCR #GPCR #IndustryNews

  • The microglial endocannabinoid system similarly regulated by lipopolysaccharide and interferon gamma

    Thus, we systematically investigated the relationship between the concentration of two distinct pro-inflammatory Furthermore, we demonstrate that the efficacy of different synthetic cannabinoid treatments with respect This indicates that different pro-inflammatory stimuli influence the capacity of microglia to synthesize , degrade, and respond to cannabinoids which has implications for the development of cannabinoid-based Read more at the source #DrGPCR #GPCR #IndustryNews

  • Label-free LC-MS based assay to characterize small molecule compound binding to cells

    Here we developed and validated a label-free, liquid chromatography-mass spectrometry (LC-MS) based cell various target classes, with particular emphasis on those for which protein-based binding assay can be difficult In another example, this assay was applied to an ion channel target with its agonists, of which the determined Read more at the source #DrGPCR #GPCR #IndustryNews

  • Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System

    October 2022 "Pepducins are small-lipidated peptides designed from the intracellular loops of G protein-coupled Over the past 2 decades, pepducins have progressed initially from pharmacologic tools used to manipulate To date, pepducins designed from numerous GPCRs have been studied for their impact on pathologic conditions We will discuss the historic context of pepducin development for each receptor, as well as the structural Read more at the source #DrGPCR #GPCR #IndustryNews

bottom of page